Primus Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsPrimus Pharmaceuticals

Primus Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Impoyz	Clobetasol	2017-11-28	2025-2035	Inflammation , Dermatitis , Facial dermatoses , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses
Metaxalone	Metaxalone	2015-06-01	2026	Myositis , Pain , Muscle spasticity , Muscle cramp , Spasm , Muscle rigidity
Sernivo	Betamethasone	2016-02-05	2027-2039	Psoriasis , Atopic dermatitis , Pruritus ani , Inflammation , Facial dermatoses , Seborrheic dermatitis , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses , Mycoses , Oral candidiasis , Vulvovaginal candidiasis , Tinea pedis , Cutaneous candidiasis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

pathologic constriction

,

spinal stenosis

,

,

cognitive dysfunction

,

,

healthy volunteers/patients

healthy volunteers/patients

Clobetasol propionate

healthy volunteers/patients

Betamethasone dipropionate

healthy volunteers/patients

myocardial infarction

,

coronary disease

,

type 2 diabetes mellitus

,

,

systemic scleroderma

,

diffuse scleroderma

,

,

,

acquired immunodeficiency syndrome

colorectal neoplasms

,

,

squamous cell carcinoma of head and neck

,

biliary tract neoplasms

type 2 diabetes mellitus

,

diabetes mellitus

,

insulin resistance

metabolic bone diseases

,

Bos taurus adrenal cortex corticosteroids

,

precursor cell lymphoblastic leukemia-lymphoma

,

,

respiratory insufficiency

,

,

bronchiolitis obliterans syndrome

,

giant cell arteritis

,

polymyalgia rheumatica

,

lupus nephritis

,

multiple myeloma

,

breast neoplasms

,

,

,

animal mammary neoplasms

,

ornithine carbamoyltransferase deficiency disease

,

,

,

,

,

pulmonary sarcoidosis

,

,

,

b-cell chronic lymphocytic leukemia

,

hypersensitivity

,

,

healthy volunteers/patients

,

,

,

systemic lupus erythematosus

,

prostatic neoplasms

,

urogenital neoplasms

,

male genital neoplasms

,

hematopoietic stem cell transplantation

,

,

granulomatosis with polyangiitis

,

anti-neutrophil cytoplasmic antibody-associated vasculitis

,

microscopic polyangiitis

,

obstructive lung diseases

,

,

graft rejection

,

psychology rejection

,

thrombocytopenic purpura idiopathic

,

follicular lymphoma

,

,

thrombocytopenia

,

,

nephrotic syndrome

,

,

,

,

,

kidney transplantation

,

,

chronic obstructive pulmonary disease

,

graft vs host disease

,

liver transplantation

,

atopic dermatitis

,

,

,

renal insufficiency

,

chronic kidney failure

,

kidney diseases

,

,

cytomegalovirus infections

,

communicable diseases

,

heart transplantation

,

multiple sclerosis

,

,

chronic renal insufficiency

,

,

renal replacement therapy

,

drug-related side effects and adverse reactions

,

,

relapsing-remitting multiple sclerosis

,

cystic fibrosis

,

allergic bronchopulmonary aspergillosis

,

transplantation

,

end stage liver disease

,

,

disease progression

,

,

knee osteoarthritis

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use